Literature DB >> 16419421

Photodynamic therapy for subfoveal classic choroidal neovascularization related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like).

Laurence Postelmans1, Brigitte Pasteels, Pascale Coquelet, Laure Caspers, Claire Verougstraete, Anita Leys, Mieke Wirix, Martine Mauget-Faÿsse, Maddalena Quanranta, Bernadette Snyers, Erica Smets.   

Abstract

PURPOSE: To evaluate the safety and efficacy of photodynamic therapy with verteporfin (PDT) for subfoveal classic choroidal neovascularization (CNV) related to punctate inner choroidopathy (PIC) or presumed ocular histoplasmosis-like syndrome (POHS-like).
METHODS: Retrospective review of 16 eyes from 14 patients with subfoveal classic CNV associated with PIC or POHS-like and treated with PDT.
RESULTS: The mean visual acuity increased from 4.5/10 (range: 1/10-9/10) to 7/10 (range: 2/10-10/10) after a mean follow-up of 21 months (range: 8-32 months) and a mean number of 2 PDT (range: 1-6). Visual acuity remained stable or improved in 13 of the 16 eyes (81%) and decreased in three.
CONCLUSION: This nearly two-year follow-up study suggests that PDT could be helpful for patients with subfoveal classic CNV related to PIC or POHS-like.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16419421     DOI: 10.1080/09273940590951124

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  9 in total

Review 1.  Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment.

Authors:  Narendra Dhingra; Susan Kelly; Mohammed A Majid; Claire B Bailey; Andrew D Dick
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

2.  Photodynamic therapy for choroidal neovascularization in young adult patients.

Authors:  Rita Ehrlich; Michal Kramer; Irit Rosenblatt; Dov Weinberger; Karin Mimouni; Ethan Priel; Ruth Axer-Siegel
Journal:  Int Ophthalmol       Date:  2010-02-02       Impact factor: 2.031

Review 3.  [White dot syndrome].

Authors:  W Göbel
Journal:  Ophthalmologe       Date:  2008-01       Impact factor: 1.059

Review 4.  Verteporfin PDT for non-standard indications--a review of current literature.

Authors:  Wai Man Chan; Tock-Han Lim; Alfredo Pece; Rufino Silva; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-17       Impact factor: 3.117

5.  Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature.

Authors:  Dimitrios Brouzas; Antonios Charakidas; Tryfon Rotsos; Marilita M Moschos; Helen Loukianou; Chryssanthy Koutsandrea; Ioannis Ladas; Stefanos Baltatzis
Journal:  Clin Ophthalmol       Date:  2010-08-09

Review 6.  Punctate inner choroidopathy: a systematic review.

Authors:  Joana Campos; António Campos; Sílvia Mendes; Arminda Neves; Diana Beselga; Jp Castro Sousa
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

7.  Combined treatment in punctate inner choroidopathy.

Authors:  Barbara Terelak-Borys; Katarzyna Zagajewska; Irmina Jankowska-Lech; Piotr Tesla; Iwona Grabska-Liberek
Journal:  Ther Clin Risk Manag       Date:  2016-09-23       Impact factor: 2.423

8.  Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor.

Authors:  Rupak Roy; Kumar Saurabh; Aditya Bansal; Amitabh Kumar; Anindya Kishore Majumdar; Swakshyar Saumya Paul
Journal:  Indian J Ophthalmol       Date:  2017-04       Impact factor: 1.848

Review 9.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.

Authors:  Aniruddha Agarwal; Alessandro Invernizzi; Rohan Bir Singh; William Foulsham; Kanika Aggarwal; Sabia Handa; Rupesh Agrawal; Carlos Pavesio; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.